The results indicated that the expression of FCGR2A was significantly upregulated and acted as a risk factor in most types of cancers, such as lung adenocarcinoma (LUAD) and head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene FCGR2A and cancer.